page | Related news | rheumatology.medicinematters.com

page | Related news | rheumatology.medicinematters.com Skip to main content

Home

Latest news

Browse topics

Rheumatoid arthritis

Spondyloarthropathies

Browse all topics

In focus

Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA

Anifrolumab for the treatment of SLE

JAK inhibitor safety: Weighing up the data and understanding the risks

Rituximab and rheumatology practice in the COVID-19 era

Safety snapshot: Upadacitinib in patients with PsA

Repurposing rheumatology drugs for COVID-19

Telemedicine in rheumatology: COVID-19 and beyond

Managing PsA in resource-limited settings

Conferences

ACR Convergence 2022

EULAR 2022 Congress

About us

Medicine Matters Rheumatology

Medicine Matters Rheumatology

EXTENDED SEARCH

Medicine Matters Rheumatology

JAVASCRIPT NEEDED

Please enable JavaScript on your browser, so that you can use all features of this website.

INTERNET EXPLORER IS NO LONGER SUPPORTED

Your version of Internet Explorer is no longer supported by this system. Please install one of the following browsers: Microsoft Edge, Safari, Chrome or Firefox

Related news

Home
Latest news
Browse topics
In focus
Conferences
- ACR Convergence 2022
- EULAR 2022 Congress
About us

About us

What is Medicine Matters?

Editorial policy

Help and support

Terms and Conditions

Manage cookies/Do not sell my data

Legal disclaimer

Advertise with us

Other sites

Medicine Matters diabetes

Medicine Matters oncology

Share this:

Follow us:

Copyright © 2023 Springer Healthcare Limited. Part of the Springer Nature Group.

Version: 0.2756.0